Guatemala — Fruit and Fruit Products

← back to leaderboard

Guatemala received 81 FDA import refusals in Fruit and Fruit Products between 2023-Q4 and 2026-Q3. Volume peaked at 33 in 2026-Q2, with the trend rising sharply year-on-year. The most-cited issues are mfr insan, mfr inj, and unsafe col. No trade baseline is published for this commodity from Guatemala, so no per-$1B rate is shown here.

Of these, 69 were hazard refusals and 12 were paperwork refusals.

Exporting from Guatemala? Get an email when shipments from Guatemala are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

4 2023-Q4 2023-Q4: 4 6 2024-Q1 2024-Q1: 6 2 2024-Q2 2024-Q2: 2 3 2024-Q3 2024-Q3: 3 13 2024-Q4 2024-Q4: 13 0 2025-Q1 2025-Q1: 0 3 2025-Q2 2025-Q2: 3 7 2025-Q3 2025-Q3: 7 2 2025-Q4 2025-Q4: 2 4 2026-Q1 2026-Q1: 4 33 2026-Q2 2026-Q2: 33 4 2026-Q3 2026-Q3: 4

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Citrus 34 922.2 no english
Berries-Grapes 6 172.8 mfr insan
Fruit-Other 39 mfr insan
Tropical 2 pesticide

Recent rejections